Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
ROIC: Returns DecliningContracting
Percentile Rank50
Studio
Year-over-Year Change

Return on invested capital

Latest
-25.28%
↑ 17% vs avg
Percentile
P50
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-30.40%
Historical baseline
PeriodValueYoY Change
2025-25.28%-1.5%
2024-24.91%-98.1%
2023-12.57%+73.4%
2022-47.19%-12.2%
2021-42.07%-